文献速递放疗物理与技术中枢神经肿瘤放疗胸部肿瘤放疗

极高能电子线治疗作为光粒子替代方案用于透射质子FLASH治疗的剂量学性能评估

Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances.
PubMed 文献 · Radiother Oncol · 2024-02-18

该研究通过蒙特卡洛模拟比较极高能电子线(VHEE,50-250 MeV)与透射质子(TP,200-250 MeV)的物理特性,并对胶质母细胞瘤、食管癌和前列腺癌病例进行剂量学规划比较。结果显示,能量≥150 MeV的VHEE计划剂量学质量与250 MeV TP计划相当。

要点

  • 能量>100 MeV的VHEE可像TP一样实现大致平坦(±20%以内)的深度剂量分布。
  • 靶区适形度和危及器官保护由侧向束半影决定,400[500] MeV电子束匹配200[250] MeV TP束半影。
  • 对胶质母细胞瘤和食管癌病例,100 MeV VHEE计划虽适形度降低,但靶区覆盖和危及器官保护与TP相似。

核心结论

  • 使用足够高束能量的VHEE-based FLASH-RT可能作为TP-based FLASH-RT的轻粒子替代方案,具有相当的剂量学计划质量。

研究设计与样本

  • 本研究采用蒙特卡洛模拟在水中比较VHEE与TP束的基本物理特性。
  • 使用支持VHEE的研究性治疗计划系统,对胶质母细胞瘤、食管癌和前列腺癌病例评估不同能量VHEE束与250 MeV TP束的计划质量。

主要发现

  • 能量>100 MeV的VHEE可像TP一样以大致平坦(±20%以内)的深度剂量分布治疗靶区。
  • 400[500] MeV电子束匹配200[250] MeV TP束的半影,较低电子能量半影增加。
  • 对研究的患者病例,能量≥150 MeV的VHEE计划达到与250 MeV TP计划相当的剂量学计划质量。
  • 对胶质母细胞瘤和食管癌病例,即使100 MeV VHEE计划适形度降低,也提供与TP相似的靶区覆盖和危及器官保护。

关键数值与推荐

  • VHEE能量范围为50-250 MeV,TP束能量为200-250 MeV,比较中使用的TP束能量为250 MeV。
  • 深度剂量分布平坦性标准为±20%以内。
  • 400[500] MeV电子束的半影与200[250] MeV TP束匹配。
  • 能量≥150 MeV的VHEE计划剂量学质量与250 MeV TP计划相当。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Clinical translation of FLASH-radiotherapy (RT) to deep-seated tumours is still a technological challenge. One proposed solution consists of using ultra-high dose rate transmission proton (TP) beams of about 200-250 MeV to irradiate the tumour with the flat entrance of the proton depth-dose profile. This work evaluates the dosimetric performance of very high-energy electron (VHEE)-based RT (50-250 MeV) as a potential alternative to TP-based RT for the clinical transfer of the FLASH effect. METHODS: Basic physics characteristics of VHEE and TP beams were compared utilizing Monte Carlo simulations in water. A VHEE-enabled research treatment planning system was used to evaluate the plan quality achievable with VHEE beams of different energies, compared to 250 MeV TP beams for a glioblastoma, an oesophagus, and a prostate cancer case. RESULTS: Like TP, VHEE above 100 MeV can treat targets with roughly flat (within ± 20 %) depth-dose distributions. The achievable dosimetric target conformity and adjacent organs-at-risk (OAR) sparing is consequently driven for both modalities by their lateral beam penumbrae. Electron beams of 400[500] MeV match the penumbra of 200[250] MeV TP beams and penumbra is increased for lower electron energies. For the investigated patient cases, VHEE plans with energies of 150 MeV and above achieved a dosimetric plan quality comparable to that of 250 MeV TP plans. For the glioblastoma and the oesophagus case, although having a decreased conformity, even 100 MeV VHEE plans provided a similar target coverage and OAR sparing compared to TP. CONCLUSIONS: VHEE-based FLASH-RT using sufficiently high beam energies may provide a lighter-particle alternative to TP-based FLASH-RT with comparable dosimetric plan quality.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Böhlen TT, Germond JF, Desorgher L, et al. Very high-energy electron therapy as light-particle alternative to transmission proton FLASH therapy - An evaluation of dosimetric performances. Radiother Oncol. 2024. PMID: 38378075. doi:10.1016/j.radonc.2024.110177

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。